Quick Asked: Nexstim Contact Us?

Are you searching for Nexstim Contact Us? By using our below available official links ( which are always up to date), you can find contact information without any difficulty. It may list Phone number, Mobile phone, Email Address & Customer service information.
Last update: 11 May, 2024 192 Views

What is nexstim? Nexstim is the world leader in image-guided transcranial magnetic stimulation (TMS) Founded in 2000 in Helsinki, Finland, Nexstim is committed to improving the quality of life of patients with significant unmet clinical needs.

Did nexstim receive an nbs system order from a university hospital? Press release, Helsinki, 29 July 2021 at 10 AM (EEST) Nexstim Receives an NBS System Order from a University Hospital in Germany Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company") announces that it has received an NBS System order in Germany. The customer is a German university hospital and a new customer for Nexstim.

When will nexstim report its half yearly report be released? Company announcement, Helsinki, 9 August 2021 at 11 AM (EEST) Notice of Nexstim Plc’s Half-Yearly Report H1 2021 Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company") will publish its half-yearly report for the six months ended 30 June 2021 on Friday 13 August 2021 at approximately 9:00 am Finnish time.

What did nexstim announce on 10 august 2021? Press release, Helsinki, 10 August 2021 at 10:00 AM (EEST) Nexstim Receives a New NBS System Order from the Medical University of South Carolina Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company") announces that it has received an NBS system order from the Medical University of South Carolina (MUSC) in the United States.

Listing Results Nexstim Contact Us? Question Answers

Nexstim News

News. Nexstim offers targeted and effective therapies and diagnostics for challenging brain diseases and disorders. Our technology is solidly grounded in scientific and clinical research. We closely collaborate with key opinion leaders who, like us, believe noninvasive brain stimulation harnesses the brain's own healing power—neuroplasticity.

Nexstim heads to US after accidentally treating the sham

Failure of a pivotal US trial would put a lot of companies off pursuing FDA clearance. Not Nexstim. The Finnish group’s electric field-based stroke therapy, called NBT, missed the primary endpoint of the phase III Niche trial last month owing to a high response rate in the sham group, but the company will press on anyway with a de novo 510(k) application.

Did the information help you? If so, please share!
If you think the information on this page has been helpful to you, would you be willing to share it? Your sharing is the driving force for our continuous work.
  1. Home ›
  2. N ›
  3. Nexstim Contact Us?